These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18287965)

  • 1. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice.
    Mok E; Constantin B; Favreau F; Neveux N; Magaud C; Delwail A; Hankard R
    Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
    Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
    Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia.
    Cruzat VF; Bittencourt A; Scomazzon SP; Leite JS; de Bittencourt PI; Tirapegui J
    Nutrition; 2014 May; 30(5):602-11. PubMed ID: 24698353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased oxidative stress in dystrophin deficient (mdx) mice masticatory muscles.
    Spassov A; Gredes T; Gedrange T; Pavlovic D; Lupp A; Kunert-Keil C
    Exp Toxicol Pathol; 2011 Sep; 63(6):549-52. PubMed ID: 20471229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
    Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
    Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
    Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
    Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral supplementation with glutamine and alanyl-glutamine on glutamine, glutamate, and glutathione status in trained rats and subjected to long-duration exercise.
    Cruzat VF; Tirapegui J
    Nutrition; 2009 Apr; 25(4):428-35. PubMed ID: 19056244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice.
    Kaczor JJ; Hall JE; Payne E; Tarnopolsky MA
    Free Radic Biol Med; 2007 Jul; 43(1):145-54. PubMed ID: 17561103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy.
    Hibaoui Y; Reutenauer-Patte J; Patthey-Vuadens O; Ruegg UT; Dorchies OM
    J Pineal Res; 2011 Sep; 51(2):163-71. PubMed ID: 21486366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle.
    Smythe GM; Forwood JK
    Muscle Nerve; 2012 Sep; 46(3):374-83. PubMed ID: 22907228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
    Hodgetts S; Radley H; Davies M; Grounds MD
    Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of Oxidative Damage and Inflammatory Response in the Diaphragm Muscle of mdx Mice Using Iron Chelator Deferoxamine.
    Moraes LH; de Burgos RR; Macedo AB; de Almeida Hermes T; de Faria FM; Minatel E
    Biol Trace Elem Res; 2015 Sep; 167(1):115-20. PubMed ID: 25762099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alanyl-glutamine and glutamine plus alanine supplements improve skeletal redox status in trained rats: involvement of heat shock protein pathways.
    Petry ER; Cruzat VF; Heck TG; Leite JS; Homem de Bittencourt PI; Tirapegui J
    Life Sci; 2014 Jan; 94(2):130-6. PubMed ID: 24269578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice.
    Terrill JR; Boyatzis A; Grounds MD; Arthur PG
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2097-108. PubMed ID: 23892094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
    Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
    Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse.
    Siegel AL; Bledsoe C; Lavin J; Gatti F; Berge J; Millman G; Turin E; Winders WT; Rutter J; Palmeiri B; Carlson CG
    Neuromuscul Disord; 2009 Feb; 19(2):131-9. PubMed ID: 19054675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary glutamine on tumor glutathione levels and apoptosis-related proteins in DMBA-induced breast cancer of rats.
    Todorova VK; Harms SA; Kaufmann Y; Luo S; Luo KQ; Babb K; Klimberg VS
    Breast Cancer Res Treat; 2004 Dec; 88(3):247-56. PubMed ID: 15609127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
    Radley HG; Davies MJ; Grounds MD
    Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.
    Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L
    Neuroscience; 2006 Jul; 140(3):835-48. PubMed ID: 16650610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
    Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
    Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.